GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,785,000 | -12.7% | 250,000 | 0.0% | 0.48% | -31.4% |
| Q2 2020 | $15,783,000 | +23.6% | 250,000 | 0.0% | 0.69% | -20.3% |
| Q1 2020 | $12,773,000 | -35.7% | 250,000 | 0.0% | 0.87% | -22.5% |
| Q4 2019 | $19,873,000 | +63.8% | 250,000 | 0.0% | 1.12% | +27.9% |
| Q3 2019 | $12,130,000 | -7.8% | 250,000 | 0.0% | 0.88% | -22.3% |
| Q2 2019 | $13,150,000 | -0.6% | 250,000 | 0.0% | 1.13% | -26.1% |
| Q1 2019 | $13,233,000 | -53.9% | 250,000 | -64.3% | 1.53% | -56.9% |
| Q4 2018 | $28,735,000 | – | 700,000 | – | 3.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |